NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
ID: 348386Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the NEI Collaborative Clinical Vision Research: Chair's Grant (UG1), a federal grant aimed at supporting large-scale clinical trials focused on screening, diagnosing, preventing, or treating vision disorders. This cooperative agreement emphasizes the need for comprehensive study organization and oversight, requiring applicants to submit detailed clinical protocols, milestone plans, and a clear delineation of roles and responsibilities. The funding opportunity is particularly significant for advancing vision science and improving public health outcomes, with eligibility extended to a diverse range of organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is May 25, 2026, and can find further details and guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Eye Institute (NEI) is inviting applications for its Collaborative Clinical Vision Research: Chair's Grant (UG1), aimed at supporting large-scale clinical trials encompassing screening, diagnosing, preventing, or treating vision disorders. This grant extends to various activities in vision health and requires compliance with stringent application protocols and deadlines, including the use of NIH's FORMS-H application packages starting January 2023. The grant is designed to provide substantial federal involvement in the proposed clinical trials, with detailed guidelines on application content, including a clinical protocol, milestone plans, and study organization. Eligible applicants span a wide range of organizations, including higher education institutions and nonprofits. The funding opportunity is set with specific timelines for submission, merit review, and award dates leading up to May 2026. Emphasizing the importance of diverse participation, the NEI encourages applications from underrepresented groups. The NIH conducts thorough evaluations of applications based on scientific merit, organizational capability, and the potential public health impact of the proposed research. Ultimately, this funding aims to foster advancements in vision science and improve outcomes for individuals affected by vision disorders.
    Similar Opportunities
    NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the NEI Collaborative Clinical Vision Research Project, specifically seeking applications for a Coordinating Center grant under the UG1 activity code. This initiative aims to support large-scale, investigator-initiated clinical trials focused on vision disorders, including interventions for screening, diagnosing, preventing, or treating these conditions, with an emphasis on projects that require significant oversight and management. The NEI's mission is to advance vision research and enhance public health through rigorous clinical trials, ensuring compliance with NIH policies and ethical standards in research involving human subjects. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by May 25, 2026, and can find further details at the provided NIH grants information email: grantsinfo@nih.gov.
    NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NEI Collaborative Clinical Vision Research Project, specifically for Resource Center Grants (UG1 Clinical Trial Required). This initiative aims to support large-scale clinical trials focused on screening, diagnosing, preventing, or treating vision disorders, with a particular emphasis on evaluating complex interventions and providing essential services for multi-center trials. The NEI seeks to advance vision health through rigorous research, and applications are encouraged from a diverse range of eligible applicants, including various educational institutions and organizations. Interested parties must submit their applications by May 25, 2026, and can find additional information and guidelines at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) to support the planning and development of clinical vision research studies. This grant program aims to advance knowledge in eye and vision conditions by funding the development of study protocols and manuals, as well as fostering collaborative research efforts, while explicitly prohibiting the generation of data from clinical trials or preclinical studies. Eligible organizations, including educational institutions and nonprofits, can apply for grants of up to $150,000 per year for a maximum of two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-358.html.
    NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed), aimed at facilitating the rapid translation of innovative laboratory research into therapeutics for visual system diseases. This grant program supports the development of biological, pharmaceutical, medical device, and combination therapies, utilizing a bi-phasic, milestone-driven approach where the R61 phase focuses on preliminary research and the R33 phase advances candidates towards clinical trials. Interested applicants, including independent school districts and community-based organizations, can expect up to five awards with no cost-sharing requirement, and should prepare to submit applications by February 16, 2026, with an estimated award date of December 1, 2026. For further inquiries, contact Tony Gover, Ph.D., at tony.gover@nih.gov or call 301-529-7320.
    NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI New Innovator Award, a federal grant aimed at supporting early-stage investigators and postdoctoral candidates in vision research. This opportunity encourages innovative and original research proposals that have the potential to significantly impact the field of vision science, particularly those that explore novel methodologies or interdisciplinary approaches. The program anticipates awarding four grants, with no cost-sharing requirements, and applications are due by May 25, 2026, with an estimated award date of August 2, 2026. For further inquiries, interested applicants can contact Ed Clayton, Ph.D., at 240-987-8255 or via email at Ed.clayton@nih.gov.
    NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed). This grant aims to support meritorious research projects that utilize existing databases for secondary data analyses related to vision health, with a focus on enhancing statistical methodologies for analyzing vision data. The initiative is crucial for addressing major causes of blindness and improving the understanding of visual system development and function. Eligible applicants include a wide range of institutions, and the total project budget can reach up to $275,000 over two years. Interested parties should submit their applications by October 16, 2027, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-357.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at advancing vision health equity through multi-level interventions and community-engaged research. This initiative, led by the National Eye Institute (NEI) in collaboration with other NIH Institutes and Centers, seeks to solicit applications for research projects that address disparities in vision health. The funding opportunity is significant, with an estimated total program funding of $7 million and an award ceiling of $1 million, expecting to support approximately six awards. Interested applicants should note that the NOFO is anticipated to be published in Winter 2025, with applications due in early Spring 2025, and the estimated award date is set for December 1, 2025.
    NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44), aimed at supporting small business concerns (SBCs) conducting early-stage clinical trials related to vision disorders. Applicants are required to propose studies that evaluate interventions for screening, diagnosing, preventing, or treating eye diseases, with a focus on trials that typically fall under Phase I or II and involve greater than minimal risk, necessitating appropriate oversight and safety monitoring. This initiative underscores the government's commitment to advancing clinical research and innovation in vision health, with applications due by January 7, 2027. Interested applicants can find more information and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-066.html.
    NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program, a federal grant aimed at enhancing diversity in biomedical research through hands-on research experiences for recent college graduates from underrepresented backgrounds. This program supports educational activities that prepare participants for doctoral programs in biomedical fields, with a specific focus on vision science research, mentorship, and fostering an inclusive research environment. The maximum funding amount is $400,000 per project, with a project duration of up to five years, and applications are due by January 25, 2027. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-290.html.
    NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional), aimed at fostering innovative institutional research career development programs for clinician-vision scientists. This funding opportunity encourages institutions to prepare these professionals for independent research careers, with a focus on minimal risk clinical trials and the recruitment of scholars from underrepresented racial and ethnic groups. The program is crucial for enhancing the community of clinician investigators in vision research, with awards contingent upon NIH appropriations and a maximum project period of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with the application deadline set for June 9, 2026.